Press Releases for ANGO

Press Releases
AngioDynamics Reports Fiscal First Quarter 2010 Financial Results
AngioDynamics to Participate in the Canaccord Adams 29th Annual Growth Stock Conference
AngioDynamics, Inc. (ANGO) Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
AngioDynamics Appoints Shawn McCarthy Senior Vice President and General Manager of Its Peripheral Vascular Business Unit
AngioDynamics Reports Fiscal Fourth Quarter and Full Year 2009 Financial Results
Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
AngioDynamics to Hold Fiscal 2009 Fourth Quarter and Full Year Financial Results Conference Call on July 16, 2009
SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS
AngioDynamics to Participate in the Eighth Annual JMP Securities Research Conference
Jan Keltjens Appointed to Board of Directors of AngioDynamics
AngioDynamics to Participate in the Bank of America and Merrill Lynch 2009 Health Care Conference
AngioDynamics Reports Financial Results for Fiscal 2009 Third Quarter
AngioDynamics to Report Fiscal Third Quarter 2009 Financial Results and Hold Conference Call on April 2, 2009
AngioDynamics to Sponsor Symposium on First Human Clinical Experience with IRE Technology
AngioDynamics Acquires FlowMedica Benephit® Renal Therapy Product Line
AngioDynamics to Participate in the 27th Annual J.P. Morgan Healthcare Conference
AngioDynamics Reports Financial Results for Fiscal 2009 Second Quarter
First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics’ IRE Technology at Australia’s The Alfred Hospital
AngioDynamics to Report Fiscal Second Quarter 2009 Financial Results and Hold Conference Call on January 6, 2009
AngioDynamics Appoints Vice President, Regulatory, Quality and Clinical Affairs
AngioDynamics To Participate in Panel Discussion at RBC 2008 Healthcare Conference
AngioDynamics Implements Leadership Development Plan and Reports Preliminary Fiscal Second Quarter Financial Results
First Percutaneous Liver and Kidney Lesions Treated With AngioDynamics’ IRE Technology at Australia’s The Alfred Hospital
Gabelli & Company to Host Inaugural Best Ideas Conference - Nov 11 2008 9:01AM
AngioDynamics to Launch VenaCure EVLT(TM), New Brand for Varicose Vein Treatment
Charles Orsatti Elected to AngioDynamics' Board of Directors
Delcath Systems Appoints Eamonn Hobbs to Board of Directors
AngioDynamics Reports Financial Results for Fiscal First Quarter 2009
AngioDynamics to Hold Fiscal First Quarter Earnings Conference Call on October 2, 2008
AngioDynamics to Present at Canaccord Adams 28th Annual Global Growth Conference
AngioDynamics Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
AngioDynamics Appoints Vice President of International IRE Sales
AngioDynamics Appoints Senior Vice President of Business Development
AngioDynamics to Hold Fiscal Fourth Quarter and Full-Year 2008 Financial Results Conference Call on July 24, 2008
Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses in Patients with Lung Cancer
AngioDynamics Initiates Voluntary Recall of its Centros Catheter
AngioDynamics Completes Acquisition of U.S. and U.K. Diomed Assets
AngioDynamics Reports Preliminary Net Sales for Fiscal Fourth Quarter and Fiscal Year 2008
AngioDynamics Purchase of Certain Diomed Assets in the United States Approved by Bankruptcy Court
AngioDynamics Announces Settlement of Patent Litigation With VNUS Medical Technologies
VNUS Announces Settlement of Patent Litigation with AngioDynamics and Vascular Solutions
AngioDynamics to Participate in the 5th Annual Craig-Hallum Institutional Investor Conference - May 27 2008 12:57AM
AngioDynamics Closes Acquisition of Oncobionic - May 27 2008 12:41AM
AngioDynamics to Participate in the 2008 Bank of America Healthcare Conference - Jun 1 2008 6:48AM
First Human Use Demonstrates Effectiveness of Irreversible Electroporation Treatment
AngioDynamics Offers to Purchase Certain Diomed Assets in the United States and United Kingdom
AngioDynamics Reports Fiscal Third Quarter 2008 Financial Results and Announces Settlement of Patent Litigation With Diomed